JointMedica receive Continuity Support Grant for current Innovate UK funded projects
JointMedica receive Continuity Support Grant for current Innovate UK funded projects
JointMedica are set to benefit from a Continuity Support package, providing businesses with help to support projects which have been delayed and affected by the COVID-19 pandemic.
Monies were made available in continuity grants to SMEs and third sector organisations who are existing Innovate UK award holders to ensure the success and delivery of new innovation during the COVID-19 epidemic.
Terence Smith, Managing Director of JointMedica commented;
We are eternally grateful to the innovate UK organisation for their continued support of our development technologies. JointMedica can now continue with our work, striving towards our goals.
For further information visit www.innovateuk.gov.uk


Birmingham Prestige Awards 2019
Following our recent nomination to the Corporate Livewire Prestige Awards, we are extremely proud to announce that Jointmedica are winners of a Birmingham Prestige Award 2019 for;
Excellence in Bespoke Orthopaedic Services.
The Corporate Livewire Prestige Awards celebrates small and medium-sized enterprises consisting of localised businesses and sole traders that have thrived in their highly competitive community and have proven their success during the past 12 months.
The Awards recognise businesses that provide a personal approach towards their customers to maintain a high-quality level of service and experience.
Jointmedica are understandably delighted to be acknowledged by the judging panel beating off tough competition from 22 other companies in our category.
This latest award continues our success and run of awards, having most recently been awarded Most Advanced Orthopaedic Implant Technology Company – UK from the Global Health & Pharma Technology (GHP) Awards.
Our focus and dedication to deliver innovative solutions to the Orthopaedic industry remains our principle company value. As we continue our development journey we look forward to sharing our product developments with the broader market.